{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:01:00Z","timestamp":1783382460006,"version":"3.54.6"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Mammary analog secretory carcinoma (MASC) is a new diagnosis of head and neck tumors first reported in 2010. It was often misdiagnosed as salivary acinic cell carcinoma (AciCC). We present a patient with an asymptomatic parotid tumor that underwent deep lobe parotidectomy and postoperative radiation therapy. The final pathology showed MASC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>A 57-year-old male presented with an asymptomatic enlarging right parotid mass. A CT neck with IV contrast showed a 1.2 cm heterogeneously enhancing mass in the center of the right parotid gland without extraparotid extension. An FNA showed an epithelial neoplasm with papillary features. The patient underwent a right deep lobe parotidectomy with facial nerve dissection. The final pathology confirmed the diagnosis of MASC. He subsequently completed a 6-week course of radiation therapy and remained asymptomatic at his 30-month follow up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion\/conclusion:<\/jats:title>\n                    <jats:p>Although MASC is considered a low-grade tumor in most cases, recurrence and disseminated disease are not uncommon. No standard treatment protocol has been established. This report aims to enhance the awareness of this diagnosis and provide a review of current treatments for head and neck oncology care providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T01:54:32Z","timestamp":1547862872000},"page":"88-91","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["A case report of parotid mammary analogue secretory carcinoma and reviews"],"prefix":"10.1097","volume":"55","author":[{"given":"Luona","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teagan","family":"Thorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Shemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20260114","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am. J. Surg. Pathol"},{"key":"R2-23-20260114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-014-1701-8","article-title":"Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement","volume":"466","author":"Majewska","year":"2015","journal-title":"Virchows Arch"},{"key":"R3-23-20260114","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/PAS.0b013e3182841554","article-title":"Most nonparotid \u201cacinic cell carcinomas\u201d represent mammary analog secretory carcinomas","volume":"37","author":"Bishop","year":"2013","journal-title":"Am. J. Surg. Pathol"},{"key":"R4-23-20260114","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/lary.24254","article-title":"Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy","volume":"124","author":"Sethi","year":"2014","journal-title":"Laryngoscope"},{"key":"R5-23-20260114","first-page":"237","article-title":"Mammary Analogue Secretory Carcinoma (MASC) of the salivary gland: a new tumor entity","volume":"16","author":"Damjanov","year":"2016","journal-title":"Bosn. J. Basic Med. Sci"},{"key":"R6-23-20260114","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/DAD.0000000000000098","article-title":"A unique case of a cutaneous lesion resembling mammary analog secretory carcinoma: a case report and review of the literature","volume":"37","author":"Albus","year":"2015","journal-title":"Am. J. Dermatopathol"},{"key":"R7-23-20260114","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.4317\/medoral.19874","article-title":"Mammary analogue secretory carcinoma (MASC) of salivary gland in four Mexican patients","volume":"20","author":"Serrano-Ar\u00e9valo","year":"2015","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"R8-23-20260114","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2559.2012.04232.x","article-title":"Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands","volume":"61","author":"Chiosea","year":"2012","journal-title":"Histopathology"},{"key":"R9-23-20260114","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijsu.2016.08.014","article-title":"The SCARE statement: consensus-based surgical case report guidelines","volume":"34","author":"Agha","year":"2016","journal-title":"Int. J. Surg"},{"key":"R10-23-20260114","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5858\/arpa.2015-0075-RS","article-title":"Mammary analogue secretory carcinoma","volume":"140","author":"Stevens","year":"2016","journal-title":"Arch. Pathol. Lab. Med"},{"key":"R11-23-20260114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cyt.12465","article-title":"Additional diagnostic features of mammary analogue secretory carcinoma on cytology","volume":"29","author":"Gonzalez","year":"2018","journal-title":"Cytopathology"},{"key":"R12-23-20260114","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hed.2890090407","article-title":"Squamous cell carcinoma of salivary gland origin","volume":"9","author":"Shemen","year":"1987","journal-title":"Head Neck Surg"},{"key":"R13-23-20260114","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/014556130108001109","article-title":"Malignant lymphoepithelial lesion of the parotid gland: a case report and review of the literature","volume":"80","author":"Wu","year":"2001","journal-title":"Ear Nose Throat J"},{"key":"R14-23-20260114","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000457949","article-title":"Mammary analogue secretory carcinoma presenting as a cervical lymph node metastasis of unknown primary site: a case report","volume":"10","author":"Suzuki","year":"2017","journal-title":"Case Rep. Oncol"},{"key":"R15-23-20260114","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdw042","article-title":"What hides behind the MASC: clinical response and acquired resistance to entrectinib afterETV6-NTRK3identification in a mammary analogue secretory carcinoma (MASC)","volume":"27","author":"Drilon","year":"2016","journal-title":"Ann. Oncol"},{"key":"R16-23-20260114","doi-asserted-by":"crossref","first-page":"CT060","DOI":"10.1158\/1538-7445.AM2017-CT060","article-title":"Abstract CT060: STARTRK-2: a global phase 2, open-label, basket study of entrectinib in patients with locally advanced or metastatic solid tumors harboring TRK, ROS1, or ALK gene fusions","volume":"77","author":"Drilon","year":"2017","journal-title":"Cancer Res"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221026121930015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221026121930015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01612930-201955000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:09:26Z","timestamp":1768396166000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01612930-201955000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":16,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2019.01.004","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}